Sands Capital has announced it has closed its third life sciences fund, Sands Capital Life Sciences Pulse Fund III, with $555 million.
Through the new fund, the firm indicated it will continue to pursue businesses in private therapeutics, diagnostics, medical devices and life sciences tools businesses.
Sands Capital, founded in 1992 and based in…
Medical technology is evolving every day. What trends are investment banks seeing, and what are some of the capital trends in the medical technology space?
In this episode of The Corner Series, McGuireWoods’ Geoff Cockrell chats with Brian Scullion, senior director, medical technology at William Blair, a boutique multinational investment bank…
Applicable Provider Types: All
Is Your Entity in Compliance?
The Health Insurance Portability and Accountability Act of 1996, as modified by the Health Information Technology for Economic and Clinical Health Act of 2009 (HIPAA) requires Covered Entities (CEs), Business Associates (BAs) and Business Associate subcontractors to enter into written agreements governing each party’s rights and…
On April 19, 2024, the U.S. Environmental Protection Agency announced the designation of two per- and polyfluoroalkyl substances (PFAS)—perfluorooctanoic acid (PFOA) and perfluorooctanesulfonic acid (PFOS) and their salts and structural isomers—as hazardous substances under the Comprehensive Environmental Response, Compensation and Liability Act (CERCLA).[1] In its designation, the EPA has identified over 85 industries it believes are most likely to be directly or indirectly affected by the designation.
Vance Street Capital has announced it has closed its fourth fund, Vance Street Capital IV, with $775 million.
The fund exceeded its target of $550 million in commitments.
Through the new fund, the firm indicated it will continue to pursue businesses in the medical and life science sectors as well as a few others.
From a seller’s perspective, how does a provider group get ready for a sale process?
In this episode of The Corner Series, McGuireWoods’ Geoff Cockrell interviews Marc Anderson, managing partner of The Belay Group, on the nuances of preparing companies, particularly in healthcare services, for a sale process. The discussion highlights the…
On May 6, 2024, the Financial Crimes Enforcement Network (“FinCEN”) Director Andrea Gacki, Acting Chief of the Enforcement Division Steve Hsieh, Acting Associate Director of the Policy Division James Martinelli, and other key industry leaders, convened at SIFMA’s Anti-Money Laundering and Financial Crimes conference in New York to discuss, among other things, FinCEN’s priorities for the Corporate Transparency Act (“CTA”).
Knox Lane has announced the acquisition of All Star Healthcare Solutions.
All Star, founded in 2003 and based in Deerfield Beach, Florida, is a healthcare staffing firm that places physicians and advanced practitioners on locum tenens assignments and in permanent positions at health systems, hospitals and other healthcare facilities throughout the country.
Latticework Capital Management (LCM) has announced the closing of its latest fund with $345 million in commitments.
The new fund, LCM Healthcare Fund II, was oversubscribed, with the firm originally target $275 million. The fund will pursue control investments in founder-led lower middle market healthcare companies.
Latticework, based in Dallas, makes control equity investments…
Kain Capital has announced an investment in Essen Health Care.
Essen, founded in 1999 and based in Bronx, New York, is an independent, multi-specialty healthcare provider with over 450 practitioners across Manhattan, Bronx, Queens, Staten Island, Long Island and Westchester County.
Kain, founded in 2014 and based in New York, is a private…
